Toronto Dominion Bank
DRUG

Toronto Dominion Bank’s Bright Minds Biosciences DRUG Stock Holding History

Toronto Dominion Bank’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4
Closed – – 1842
2023
Q2 		$0 Buy
+4
New +$11 ﹤0.01% 1553

Other funds holding DRUG

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Toronto Dominion Bank's DRUG Position: Q3 2023 in Review

Toronto Dominion Bank sold out of Bright Minds Biosciences (DRUG) in Q3 2023, closing a stake of 4 shares.

Toronto Dominion Bank first reported a position in DRUG in Q2 2023 and held it in 1 quarter. The position peaked at $0 in Q2 2023. 6 funds tracked by Wall St. Rank hold DRUG as of Q3 2023.

  • Toronto Dominion Bank reported no remaining Bright Minds Biosciences position as of Q3 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 4 Bright Minds Biosciences shares in Q3 2023.
  • Toronto Dominion Bank first reported a position in Bright Minds Biosciences in Q2 2023 and held it in 1 quarter.
  • Toronto Dominion Bank's Bright Minds Biosciences position peaked at $0 in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2023.

Based on Toronto Dominion Bank's 13F filing for Q3 2023, filed 14 Nov 2023.